Here on the East Coast, it's a snowy Thursday, which means it's time to catch up on bank news. Wait, come back! There's other news, too!
NICOSIA/FRANKFURT (Reuters) - The European Central Bank will launch into quantitative easing next week having increased its economic growth forecasts for this year and next.
Pharmacyclics - AbbVie is buying the cancer drug specialist for $21 billion in cash and stock. The deal is valued at about $261.25 per share, a 13 percent premium for Pharmacyclics shareholders.
NEW YORK (Reuters) - U.S. stocks were little changed on Thursday, in the wake of two days of declines on the S&P 500, as gains were curbed by a higher-than-expected initial jobless claims report ahead of a report on factory orders.
... * BoE keeps rates at record low 0.5 pct, as expected. * Decision marks 6th anniversary of record low rates. * Strong economy points to rate hike before long.